Most Recent Articles by Sander A. Flaum
I'm not suggesting that colleges become vocational schools. But don't you think they should also help young people prepare for the life they're going to be living?
Now here comes the big question. Will the shareholders and directors of KaloBios and Allergan reward or punish their CEOs for what some may see as revenue-capping concessions?
Really? Is this the new healthcare math — the fewer the insurance companies, the greater the competition and the lower the premiums?
Until now, your superiors have promoted you. Now it's your responsibility to show why you belong.
Why would any CEO tolerate a corporate culture that holds people back?
More Articles by Sander A. Flaum
- Deloitte taps Havas Lynx's Mickelberg as MD
- Five things for pharma marketers to know: Wednesday, February 22, 2017
- Five things for pharma marketers to know: Thursday, February 23, 2017
- Five things for pharma marketers to know: Tuesday, February 21, 2017
- How VAYA Pharma used Facebook ads for its ADHD campaign